Document type
ArticleVersion
Published versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/157301
Drug-resistant Streptococcus pneumoniae
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
To the Editor: since the first description of infection caused by β-lactam-resistant Streptococcus pneumoniae, the optimal empirical antibiotic therapy for patients with suspected meningitis caused by this microorganism has remained unknown. Hofmann et al. (Aug. 24 issue)1 reported a 25 percent prevalence of penicillin-resistant S. pneumoniae isolates and a 9 percent prevalence of cephalosporin-resistant isolates among 431 patients with invasive pneumococcal infections in Atlanta. The authors recommended adding vancomycin to the initial therapeutic regimen of patients with suspected pneumococcal meningitis.
Subject (English)
Citation
Citation
PALLARÉS GINER, Roman, LIÑARES LOUZAO, Josefina and GUDIOL I MUNTÉ, Francesc. Drug-resistant Streptococcus pneumoniae. New England Journal of Medicine. 1996. Vol. 334, num. 53-55. ISSN 0028-4793. [consulted: 17 of June of 2026]. Available at: https://hdl.handle.net/2445/157301